Search the Newsreel

MapLight Therapeutics general counsel sells $607,870 in shares

MapLight Therapeutics General Counsel Kristopher Hanson sold $607,870 worth of company stock between July 15 and July 17, 2026. These sales were not discretionary but rather "sell to cover" transactions to satisfy tax obligations from restricted stock unit vesting. The company has also recently …

Maplight Therapeutics (NASDAQ:MPLT) Upgraded by BMO Capital Markets to Strong-Buy Rating

BMO Capital Markets upgraded Maplight Therapeutics (NASDAQ:MPLT) to a "strong-buy" rating. This upgrade follows several other analysts' reports, resulting in the company currently holding an average "Buy" rating and a price target of $40.09. The article also details recent insider selling activity and institutional …

BMO Capital Maintains MapLight Therapeutics(MPLT.US) With Buy Rating, Maintains Target Price $46

BMO Capital has reiterated its Buy rating for MapLight Therapeutics (MPLT.US) and maintained its price target of $46. This reflects the firm's continued positive outlook on the company's stock performance.

UBS Adjusts MapLight Therapeutics Price Target to $52 From $48, Maintains Buy Rating

UBS has increased its price target for MapLight Therapeutics to $52 from $48, while reaffirming its Buy rating on the stock. This adjustment suggests a positive outlook from UBS regarding the pharmaceutical company's future performance.

MapLight Therapeutics CEO Kroeger sells $5.4m in company stock

MapLight Therapeutics CEO Christopher A. Kroeger sold 147,639 shares of company stock for approximately $5.4 million to cover tax withholding obligations related to restricted stock units. This was a "sell to cover" transaction, not a discretionary sale. The company has also received positive analyst …

Maplebear (CART) Faces A Valuation Split, Is The Stock Cheap Or Fully Valued?

Maplebear (Instacart) is experiencing mixed stock performance, with short-term dips contrasting with positive year-to-date returns. The article presents two valuation models: one suggests the stock is 8.7% undervalued at around $50, citing operational efficiencies from AI, while another Discounted Cash Flow (DCF) model indicates …

BMO Capital Sticks to Their Buy Rating for Maple Leaf Foods (MFI)

MapLight Therapeutics (MPLT) CDO sells 36K shares via tax and plan trades

Anatol Kreitzer, Chief Discovery Officer of MapLight Therapeutics (MPLT), sold a total of 36,284 shares of Voting Common Stock between July 15 and July 17, 2026. These sales occurred at weighted-average prices ranging from $35.68 to $38.21 per share. The transactions included "sell to …

MapLight Therapeutics (MPLT) CAO and interim CFO reports 36,979-share stock sale

Jonathan Gillis, CAO and interim CFO of MapLight Therapeutics (MPLT), reported selling 36,979 shares of Voting Common Stock between July 15-17, 2026. These sales, valued at approximately $1.37 million, occurred at weighted-average prices ranging from $35.68 to $38.37 per share. Some transactions were "sell …

Maplight Therapeutics (MPLT) holder files to sell 48,158 shares via Jefferies

A Maplight Therapeutics holder, Erin Pennock Foff, has filed to sell 48,158 common shares through Jefferies LLC, with an indicated sale date of July 15, 2026. These shares have an aggregate market value of $1,825,669.78. The seller acquired these shares through restricted stock unit …

Maplight Therapeutics (MPLT) logs planned and recent common stock sales

Maplight Therapeutics (MPLT) has filed a Form 144 notice detailing planned and recent common stock sales. The filing indicates the issuance of restricted stock unit grants on several dates and includes sales by Kris Hanson over the past three months. Jefferies LLC is also …

Is Maplebear (CART) Trading At A Discount After Its Arpalus Deal?

Maplebear (CART) stock has seen a 6.7% decline over the past year, trading around US$45.82, placing its valuation as "about right" rather than clearly cheap or expensive. While the acquisition of Arpalus is expected to boost margins and revenue quality, there are risks from …

MapLight Therapeutics (MPLT) CMO reports 47,158-share stock sale

MapLight Therapeutics, Inc.'s Chief Medical Officer, Erin Pennock Foff, sold a total of 47,158 shares of Voting Common Stock between July 15 and July 17, 2026. These transactions included sales made under a Rule 10b5-1 trading plan adopted in December 2025 and "sell to …

MapLight Therapeutics CSO Lillie James Woodruff sells $673K in shares By Investing.com

Lillie James Woodruff, CSO of MapLight Therapeutics (NASDAQ:MPLT), sold shares worth $673,636 to cover tax withholding obligations related to restricted stock units. Despite this "sell to cover" transaction, which is mandatory under company equity plans, MapLight Therapeutics has recently received positive analyst coverage and …

Form 144 MapLight Therapeutics For: 17 July By Investing.com

This article from Investing.com announces the filing of Form 144 for MapLight Therapeutics on July 17. Form 144 indicates an insider's intent to sell restricted or control securities. The brief notice provides the company name and date of the filing.

MapLight Therapeutics CMO sells $1.73m in stock

Erin Pennock Foff, CMO of MapLight Therapeutics (NASDAQ: MPLT), sold approximately $1.73 million worth of company stock between July 15 and July 17, 2026. A significant portion of these sales was to cover tax withholding obligations related to restricted stock units, with some shares …

MapLight Therapeutics Insiders Sold Shares Worth Over $6.7M

Insiders at MapLight Therapeutics, including the CEO, CSO, and General Counsel, sold voting common stock between July 15-17, 2026. The total value of shares sold exceeded $6.7 million, with CEO Christopher A. Kroeger accounting for over $5.4 million of the sales. Following these transactions, …

Maplebear (CART) CAO sells 3,016 shares in Rule 10b5-1 trading plan

Maplebear Inc.'s Chief Accounting Officer, Lisa Blackwood-Kapral, sold 3,016 shares of common stock at $47.64 per share on July 15, 2026. This transaction was conducted under a Rule 10b5-1 trading plan adopted on November 20, 2025. Following the sale, Blackwood-Kapral directly holds 46,835 shares …

Instacart acquires Arpalus to make it easier to scan grocery shelves (CART:NASDAQ)

Instacart (CART:NASDAQ) has acquired computer vision company Arpalus to enhance its grocery shelf intelligence. Arpalus' technology uses quick video scans to identify shelf items with over 95% accuracy, benefiting Instacart's shoppers with real-time data for better fulfillment, inventory, and in-store guidance. The acquisition aims …

Should Instacart’s AI-Driven Carrot Ads Strategy Require Action From Maplebear (CART) Investors?

Instacart (Maplebear) is drawing attention for its AI-powered grocery and retail media initiatives, particularly the Carrot Ads platform, which uses grocery-specific data for tailored AI models. While analysts see this as a competitive advantage capable of driving high-margin revenue, investors should also consider potential …

Form 144 Maplebear Inc. For: 15 July By Investing.com

This article from Investing.com reports on a Form 144 filing by Maplebear Inc. for July 15. The content is very brief, consisting mainly of the title repeated and a stock ticker for CART, followed by market data displays.

Maplebear (NASDAQ: CART) holder to sell 3,016 shares of common stock

Maplebear Inc. shareholder Lisa Blackwood-Kapral has filed a Form 144 to sell 3,016 common shares with an aggregate market value of $143,682.00 through Charles Schwab & Co., Inc. The sale is expected to occur on NASDAQ around July 15, 2026. These shares originated from …

MAP Aktif Adiperkasa Buys Sports Direct Malaysia for $149 Million

M44U Forecast — Price Target — Prediction for 2027

N2IU Forecast — Price Target — Prediction for 2027

Mapletree Pan Asia Commercial Trust Secures S$150 Million Multi-Currency Loan With Governance Covenants

Microba Life Sciences (ASX: MAP): Substantial Holder Steps Aside as Placement Reshapes the Register

Mapletree Logistics Trust (SGX:M44U) Stock Could Be 12.1% Undervalued After $75 Million Note Issue

Q1 Earnings Roundup: Instacart (NASDAQ:CART) And The Rest Of The Online Marketplace Segment

Instacart: Expanding Adjusted EBITDA As Take Rates Rise (NASDAQ:CART)

Is Maplebear Inc. (CART) A Good Stock To Buy Now?

Kalkine Market Watch: Can Microba Life Sciences (ASX:MAP) Recover from Its Recent Decline?

Maplebear Inc (NASDAQ:CART): An Affordable Growth Opportunity Worth a Fresh Look

Intermap Technologies Q1 Loss Deepens Challenging Bullish Turnaround Narratives

What Does The Future Hold For Microba Life Sciences Limited (ASX:MAP)? These Analysts Have Been Cutting Their Estimates

We Like Maplebear's (NASDAQ:CART) Earnings For More Than Just Statutory Profit